The NCS Annual Meeting features three innovative keynotes with leading experts in the field.
Because of the vast workload and patient data ﬂow within critical care units, artificial intelligence and machine learning algorithms can be valuable tools for updating clinicians in real-time on their patients’ acuity and predicted trajectory. By using sensing technologies along with deep learning to integrate clinical and physiological data with real time autonomous assessment of visual cues, AI models can provide clinicians with continuously updated risk assessment and phenotyping for patients.
Azra Bihorac, MD, MS, FASN, FCCM, is the senior sssociate dean of research at the University of Florida College of Medicine. She is the R. Glenn Davis Professor of Medicine, Surgery, Anesthesiology, and Physiology & Functional Genomics; the lab Ddirector of Precision and Intelligent Systems in Medicine Research Partnership (PRISMAP); and the director of the Intelligent Critical Care Center (IC3), a multi-disciplinary center focused on developing and providing sustainable support and leadership for transformative medical AI research, education, and clinical applications to advance patients’ health in critical and acute care medicine.
Her work with IC3 addresses an unprecedented opportunity for world-leading ambient, immersive and artificial intelligence research and innovation, to transform the diagnosis, monitoring and treatment for critically and acutely ill patients using the multimodal clinical and research data and resources stemming from UF Health, one of the Florida’s largest health care systems. Dr. Bihorac's vision is to develop tools for intelligent human-centered health care that delivers optimized care tailored to a patient’s “personal clinical profile” using digital data. Through her work in national and international professional organizations in nephrology and critical care medicine, she has advocated for women physicians and scientists, promoting their equality and recognition in health care leadership, research and education.
The current political landscape has restricted access to health care for marginalized and minoritized populations, impeding patient autonomy, one of the foundational tenets of medical practice in the United States. Similar views may threaten determination of brain death and ultimately compromise organ transplantation further disenfranchising transplant recipients, the majority of whom are of minoritized populations. Learn why this may be broadly relevant to providers as well as patients in the NCS.
Dr. Monisha Kumar is a neurointensivist and clinical researcher whose area of expertise is in coagulation derangements associated with severe brain injury. She is triple boarded in neurology, vascular neurology and neurocritical care. She is an associate professor of neurology, neurosurgery, anesthesiology and critical care, vice chair of quality for the Department of Neurology, director of the Neuro-ICU at the Hospital of the University of Pennsylvania, departmental diversity search advisor, co-chair of the Intradepartmental Equity Committee and chair of the Penn Forum for Women Faculty. She serves on the NCS Board of Directors, is a member of the Executive Committee and is the board liaison to the Inclusion in Neurocritical Care Committee and prior chair of the Women in Neurocritical Care Subcommittee. She has devoted her life to promoting and advancing women of all stripes.
This session provides insight into NCS leadership's view of the society, the neurocritical care landscape and what is to come in the future. The session will feature a visionary presentation of the leadership direction for the society and an in-depth discussion of the challenges facing the NCS, the field and our patients.